Evidence map›Paper›PMID 25400790›Full record

ArticleInternational journal of clinical and experimental pathology2014

Spontaneous regression of primary extranodal marginal zone lymphoma of mucosa-associated lymphoid tissue (MALT lymphoma) colliding with invasive ductal carcinoma of the breast: a case report.

Ikuo Matsuda, Takahiro Watanabe, Yukie Enomoto, Yuichi Takatsuka, Yasuo Miyoshi, Seiichi Hirota

Abstract readCase Reports
In one paragraph

Article in International journal of clinical and experimental pathology, 2014. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed.

  1. Article
  2. Article
  3. Article
  4. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors.

Ikuo MatsudaDepartment of Surgical Pathology, Hyogo College of Medicine Hyogo, Japan.
Takahiro WatanabeDepartment of Surgical Pathology, Hyogo College of Medicine Hyogo, Japan.
Yukie EnomotoDivision of Breast and Endocrine Surgery, Department of Surgery, Hyogo College of Medicine Hyogo, Japan.
Yuichi TakatsukaDivision of Breast and Endocrine Surgery, Department of Surgery, Hyogo College of Medicine Hyogo, Japan.
Yasuo MiyoshiDivision of Breast and Endocrine Surgery, Department of Surgery, Hyogo College of Medicine Hyogo, Japan.
Seiichi HirotaDepartment of Surgical Pathology, Hyogo College of Medicine Hyogo, Japan.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Malignant lymphomas of the breast, whether they are primary or secondary, are rare diseases, constituting only around 0.1 to 0.15% of the primary neoplasm of the breast. Although the most prevalent histological subtype is diffuse large B-cell lymphoma, primary extranodal marginal zone lymphoma of mucosa-associated lymphoid tissue (MALT lymphoma) also occurs in the breast as in other extranodal sites, comprising about 15% of malignant lymphomas of the breast. In many cases, primary MALT lymphoma of the breast is low grade lymphoma, localized in the breast with indolent behavior and good prognosis. Here we report a case of spontaneous regression of primary MALT lymphoma of the breast. The lymphoma collided with invasive ductal carcinoma in the breast. Both tumors were identified in the Vacora biopsy specimen before the operation. However, the lymphoma disappeared, while the carcinoma remained, in the resected mass. To our knowledge, this is the first case report of spontaneous regression of MALT lymphoma of the breast colliding with breast cancer.

Indexed as

Neoplasm Regression, SpontaneousBiomarkers, TumorBiopsyBreast NeoplasmsCarcinoma, Ductal, BreastFemaleHumansImmunohistochemistryLymphoma, B-Cell, Marginal ZoneMammographyMiddle AgedNeoplasm InvasivenessNeoplasms, Multiple PrimaryPredictive Value of TestsTreatment OutcomeBiomarkers, Tumorbreastinvasive ductal carcinomaMALT lymphomaspontaneous regression

Identifiers

PMID25400790
PMCPMC4230083

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.